V
Velarion™Intelligence
Sign InFree TrialBook a Walkthrough

ZimVie Executive Compensation (FY24)

ZIMV · Executive and director compensation, fiscal 2022 to 2024

The ZimVie brief, $1,500

Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
From $1,200 for the board report; $2,400 for both.
Data as of September 12, 2026Latest filing (8-K): May 13, 2025
4 filings cited on this page
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
ZimVie brief$1,500Get the executive brief
177 figures on this page: 174 cited to the filing that reported them, 3 calculated from figures it prints. See the citations
Chief executive, fiscal 2024
◇
Vafa Jamali
Latest say-on-pay support
=
May 7, 2025
Chief executive pay ratio
◇
To the median employee
What changed from fiscal 2023 to fiscal 2024
The figures that moved, and by how much. Analysis of these figures is part of the Velarion platform.
Chief executive total compensation — Vafa Jamali: $4,226,944 → $7,209,869 (70.6% higher)
Say-on-pay support: 97.9% → 54.7% (43.2 points lower)

Frequently asked questions

Answers drawn from the data on this page.
Who is ZimVie's chief executive and what were they paid?
Vafa Jamali was paid $7,209,869 in total compensation as President and Chief Executive Officer for fiscal 2024. Jamali's total moved 70.6% higher from the $4,226,944 reported for fiscal 2023.
What was ZimVie's say-on-pay result?
For fiscal 2024, shareholders backed the say-on-pay proposal with 54.7% of votes cast for or against in favor at the meeting held May 7, 2025.
Which companies are in ZimVie's peer group?
The disclosed peer group names Alphatec Holdings, Inc., Artivion, Inc., AtriCure, Inc., Avanos Medical, Inc. and Bioventus Inc., among others.
What is ZimVie's chief executive pay ratio?
The disclosed chief executive pay ratio for fiscal 2024 is 81:1, against median employee compensation of $88,746.

Executive compensation

Every element reported for each named executive officer, by fiscal year.
Fiscal 2022
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Vafa Jamali
President and Chief Executive Officer
◇—◇◇◇—◇◇
Richard Heppenstall
Executive Vice President, Chief Financial Officer and Treasurer
◇—◇◇◇—◇◇
Indraneel Kanaglekar
Senior Vice President, Chief Commercial Officer
◇—◇◇◇—◇◇
Heather Kidwell
Senior Vice President, Chief Legal, Compliance and Human Resources Officer and Corporate Secretary
◇—◇◇◇—◇◇
Fiscal 2023
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Vafa Jamali
President and Chief Executive Officer
◇—◇—◇—◇◇
Richard Heppenstall
Executive Vice President, Chief Financial Officer and Treasurer
◇—◇—◇—◇◇
Indraneel Kanaglekar
Senior Vice President, Chief Commercial Officer
◇—◇—◇—◇◇
Heather Kidwell
Senior Vice President, Chief Legal, Compliance and Human Resources Officer and Corporate Secretary
◇—◇—◇—◇◇
Fiscal 2024
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Vafa Jamali
President and Chief Executive Officer
◇—◇———◇◇
Richard Heppenstall
Executive Vice President, Chief Financial Officer and Treasurer
◇—◇———◇◇
Heather Kidwell
Senior Vice President, Chief Legal, Compliance and Human Resources Officer and Corporate Secretary
◇—◇———◇— not reconciled
Indraneel Kanaglekar
Senior Vice President, Chief Commercial Officer
◇—◇———◇— not reconciled
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. A negative change in pension value is shown but, as the company reports it, not included in the total.

Equity awards granted

Individual awards as disclosed: type, date, unit counts at each level, and grant date value.
Fiscal 2024
OfficerAwardGrant dateThreshold unitsTarget unitsUnits grantedMaximum unitsExercise priceGrant date fair value
Heather KidwellRSU◇——◇——◇
Heather KidwellConversion◇—————◇
Indraneel KanaglekarRSU◇——◇——◇
Indraneel KanaglekarConversion◇—————◇
Richard HeppenstallConversion◇—————◇
Richard HeppenstallRSU◇——◇——◇
Vafa JamaliConversion◇—————◇
Vafa JamaliRSU◇——◇——◇
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. Threshold, target and maximum apply only to performance awards and are never shown for time-based or option awards.

Outstanding awards

Awards still held at fiscal year end.
As disclosed at fiscal 2024 year end
OfficerAwardUnvested unitsMarket value of unvested unitsExercise priceExpires
Heather KidwellOption◇—◇03/10/2032
RSU◇◇——
RSU◇◇——
RSU◇◇——
Option◇—◇02/25/2031
RSU◇◇——
Vafa JamaliOption◇—◇03/01/2031
Option◇—◇04/01/2032
RSU◇◇——
RSU◇◇——
Option◇—◇02/25/2031
RSU◇◇——
RSU◇◇——
Option◇—◇03/10/2032
RSU◇◇——
RSU◇◇——
Indraneel KanaglekarOption◇—◇02/25/2031
RSU◇◇——
Option◇—◇07/01/2031
RSU◇◇——
RSU◇◇——
Option◇—◇03/10/2032
RSU◇◇——
RSU◇◇——
Richard HeppenstallRSU◇◇——
RSU◇◇——
RSU◇◇——
Option◇—◇03/10/2032
Option◇—◇10/01/2031
RSU◇◇——
RSU◇◇——
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.

Director compensation

What each non-employee director was paid.
Fiscal 2024
DirectorFees earned in cashStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
David King
Board chair
◇◇————◇
Karen Matusinec
◇◇————◇
Vinit Asar
Lead independent director
◇◇————◇
Richard Kuntz, M.D., M.Sc
◇◇————◇
Sally Crawford
◇◇————◇
Vafa Jamali served on the board in fiscal 2024 and received no compensation for board service. Executive directors are typically paid through their executive roles, shown above.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.

Director fee schedule

The standing retainers and premiums the board pays, as published.
Board cash retainer◇
Board equity retainer◇
Total board retainer◇
Board chair premium◇
Audit committee chair◇
Compensation committee chair◇
Nominating and governance chair◇
Equity is delivered as restricted stock units.

Disclosed peer group

The companies this board named as its compensation comparison group. The list is disclosure; the comparison is analysis.
Fiscal 2024
  • Alphatec Holdings, Inc. ATEC
  • Artivion, Inc. AORT
  • AtriCure, Inc. ATRC
  • Avanos Medical, Inc. AVNS
  • Bioventus Inc. BVS
  • CONMED Corporation CNMD
  • Embecta Corp. EMBC
  • Envista Holdings Corporation NVST
  • Glaukos Corporation GKOS
  • Globus Medical, Inc. GMED
  • Haemonetics Corporation HAE
  • ICU Medical, Inc. ICUI
  • Inogen, Inc. INGN
  • Integer Holdings Corporation ITGR
  • Integra LifeSciences Holdings Corporation IART
  • LivaNova PLC LIVN
  • Merit Medical Systems, Inc. MMSI
  • Nevro Corp. NVRO
  • NuVasive, Inc. NUVA
  • Orthofix Medical Inc. OFIX
  • Paragon 28, Inc. FNA
  • Varex Imaging Corporation VREX

Say-on-pay history

Shareholder support for the compensation program, by year.
YearMeetingSupportVotes forVotes againstAbstentions
2024May 7, 2025=◇◇◇
2023May 15, 2024=◇◇◇
2022May 12, 2023=◇◇◇

Chief executive pay ratio

As calculated and reported by the company.
Ratio
◇
Median employee compensation
◇
Chief executive total compensation
◇
Email me this page as a cited PDF
The same figures, the same citations, formatted to hand to a committee. Nothing is added that is not on this page.
Your address is used for this and nothing else. Unsubscribe in one click.
Tell me when ZimVie files
You get a note when this company’s compensation data changes.
Your address is used for this and nothing else. Unsubscribe in one click.

What this page does not include

Everything above is a fact ZimVie disclosed, and it is free. Everything below is our analysis of those facts, and it is not.
Peer benchmarking
Where ZimVie sits against its disclosed peers — percentile position by role and by pay element, and the ranking behind it. The disclosed peer group is free; comparisons across it are part of the Velarion platform.
Executive Compensation Report — $1,500
Written compensation analysis
A read of the pay program as designed and as paid: incentive structure, goal rigor, the alignment between the committee's stated philosophy and what the numbers show.
Executive Compensation Report — $1,500
Board and governance analysis
Committee composition, independence, director pay positioning, and the governance provisions read together rather than listed.
Board Governance Report — $1,200
Realizable pay
What the awards above are actually worth today against what they were valued at on grant, and what the gap says about the pay-for-performance link.
Velarion Intelligence
Say-on-pay responsiveness
ZimVie recorded a low support level. The responsiveness analysis covers what the company said it would do, what it did, and how that compares with the companies that recovered their vote.
Responsiveness analysis
Adviser switching and vote outcomes
Two datasets covering compensation-adviser changes and what followed a contested vote. Both are part of the Velarion platform.
Inquire about access
Multiple companies at once
Cross-company views, cohort screens, and data export across the industries we cover. This page is one company; the platform is all of them.
Velarion Intelligence
Join the list for a Velarion Pro seat
Full platform access for one person: every industry we cover, peer positioning, and the written analysis. We will email you when it opens.
Your address is used for this and nothing else. Unsubscribe in one click.
Join the list for Peer Group Review
Whether ZimVie's disclosed peer group is defensible, who names ZimVie back in their own benchmarking group, and how pay tracks performance across it. This is the analysis a compensation consultant delivers on the group above. We will email you when it opens.
Your address is used for this and nothing else. Unsubscribe in one click.

Citations

Every figure on this page is cited to the document that reported it. Select any figure to see its citation.
177 figures on this page: 174 cited to the filing that reported them, 3 calculated from figures it prints.
174 cited to the filing
3 calculated from the filing

Documents cited

  1. 0000950170-25-069777
    Proposal 3 – Advisory Vote to Approve Named Executive Officer Compensation For Against Abstain Broker Non-Votes
  2. 0001193125-25-061931
    2024 Summary Compensation Table · CEO Pay Ratio · Compensation of Non-Employee Directors · Grants of Plan-Based Awards in 2024 · and 1 more section
  3. 0001193125-24-141785
    Proposal 3 – Advisory Vote to Approve Named Executive Officer Compensation For Against Abstain Broker Non-Votes
  4. 0000950170-23-023035
Cite this data
This page is free to cite. Attribution we ask for:
Velarion, “ZimVie executive compensation, FY2022–FY2024.” https://intel.velarion.ai/comp/ZIMV (accessed 2026).
Short form: data: Velarion

The ZimVie brief, $1,500

Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
From $1,200 for the board report; $2,400 for both.
Get the executive briefGet the board briefNo account needed.
4 filings cited on this page
Method: intel.velarion.ai/methodology
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
Embed this data
A small, cited view of this data for your own page or newsletter. Every embed carries a visible link back here, so the attribution travels with it.
The headline figures, each with its citation.
Connect an AI assistant
Ask your own assistant about ZimVie and roughly 3,000 other US public companies, and get back the same figures on this page with the same citations. Free read access, no account. Add this to your assistant's connector settings.
Setup guide and the full list of questions it answers

Peers ZimVie discloses

The companies named in ZIMV's own disclosed peer group.

Alphatec Holdings, Inc.Artivion, Inc.AtriCure, Inc.Avanos Medical, Inc.Bioventus Inc.CONMED CorporationEmbecta Corp.Envista Holdings CorporationGlaukos CorporationGlobus Medical, Inc.Haemonetics CorporationICU Medical, Inc.Inogen, Inc.Integer Holdings CorporationIntegra LifeSciences Holdings CorporationLivaNova PLCMerit Medical Systems, Inc.Nevro Corp.NuVasive, Inc.Orthofix Medical Inc.Paragon 28, Inc.Varex Imaging Corporation

Terms on this page

Say-on-Pay VoteCEO Pay RatioMedian Employee CompensationAll companies

Free to read and cite. Redistribution or bulk use of the dataset requires a data license. Talk to us about the data license.

Cite this data
APA
Velarion Company Intelligence. (2026). Velarion database: executive and board compensation data (Version 2026Q3) [Data set]. Zenodo. https://doi.org/10.5281/zenodo.22283854
BibTeX
@misc{velarionData2026,
  author = {{Velarion Company Intelligence}},
  title = {Velarion database: executive and board compensation data},
  year = {2026},
  version = {2026Q3},
  doi = {10.5281/zenodo.22283854},
  publisher = {Zenodo},
  url = {https://doi.org/10.5281/zenodo.22283854}
}
For informational purposes only. Not investment, legal, or compensation advice.  All companies · The Pay Desk · Methodology · Terms · Privacy